Mast cells modulate the inflammatory but not the proliferative response in healing wounds

被引:141
作者
Egozi, EI [1 ]
Ferreira, AM [1 ]
Burns, AL [1 ]
Gamelli, RL [1 ]
DiPietro, LA [1 ]
机构
[1] Loyola Univ, Med Ctr, Burn & Shock Trauma Inst, Dept Surg, Maywood, IL 60153 USA
关键词
D O I
10.1046/j.1524-475X.2003.11108.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
Upon stimulation, mast cells release a heterogeneous group of factors that promote inflammation and influence cell proliferation. Mast cells accumulate at sites of injury, further suggesting a critical role in wound healing. To assess the importance of mast cells in tissue repair, we compared wound healing in mast cell-deficient WBB6F1/J-Kit(W) /Kit(W-v) (Kit(W) /Kit(W-v) ) and wild type WBB6F1/++ (WT) mice. During the inflammatory phase, neutrophil infiltration into wounds of the Kit(W) /Kit(W-v) mice was significantly less than that of WT mice (84.6 +/- 10.3 vs. 218 +/- 26.0 cells/10 high-power fields at day 3, p < 0.001), while wound macrophage and T cell infiltration were similar in both strains. The decrease in neutrophils could not be explained by changes in tumor necrosis factor-alpha or macrophage inflammatory protein-2 levels, because the amounts of these two neutrophil chemoattractants were similar in both Kit(W) /Kit(W-v) and WT mice. Surprisingly, the absence of mast cells had no effect on the proliferative aspects of wound healing, including reepithelialization, collagen synthesis, and angiogenesis. Although mast cells are known to release proangiogenic mediators, vascular endothelial growth factor levels were similar in WT and Kit(W) /Kit(W-v) mice. Moreover, levels of fibroblast growth factor-2 were increased in Kit(W) /Kit(W-v) mice (4206 +/- 107 vs. 1865 +/- 249 pg/ml, p < 0.01). These results suggest that mast cells modulate the recruitment of neutrophils into sites of injury, yet indicate that mast cells are unlikely to exert a major influence on the proliferative response within healing wounds.
引用
收藏
页码:46 / 54
页数:9
相关论文
共 54 条
[1]
Mast cells in infection and immunity [J].
Abraham, SN ;
Malaviya, R .
INFECTION AND IMMUNITY, 1997, 65 (09) :3501-3508
[2]
Ajuebor MN, 1999, J IMMUNOL, V162, P1685
[3]
Mast cells and their mediators in cutaneous wound healing active participants or innocent bystanders? [J].
Artuc, M ;
Hermes, B ;
Steckelings, UM ;
Grützkau, A ;
Henz, BM .
EXPERIMENTAL DERMATOLOGY, 1999, 8 (01) :1-16
[4]
MAST-CELL HEPARIN STIMULATES MIGRATION OF CAPILLARY ENDOTHELIAL-CELLS INVITRO [J].
AZIZKHAN, RG ;
AZIZKHAN, JC ;
ZETTER, BR ;
FOLKMAN, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1980, 152 (04) :931-944
[5]
BARBUL A, 1995, OTOLARYNG CLIN N AM, V28, P955
[6]
Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2 [J].
Biedermann, T ;
Kneilling, M ;
Mailhammer, R ;
Maier, K ;
Sander, CA ;
Kollias, G ;
Kunkel, SL ;
Hültner, L ;
Röcken, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (10) :1441-1451
[7]
Human mast cells stimulate vascular tribe formation - Tryptase is a novel, potent angiogenic factor [J].
Blair, RJ ;
Meng, H ;
Marchese, MJ ;
Ren, SL ;
Schwartz, LB ;
Tonnesen, MG ;
Gruber, BL .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (11) :2691-2700
[8]
Mast cells can secrete vascular permeability factor vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of Fcε receptor I expression [J].
Boesiger, J ;
Tsai, M ;
Maurer, M ;
Yamaguchi, M ;
Brown, LF ;
Claffey, KP ;
Dvorak, HF ;
Galli, SJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (06) :1135-1145
[9]
EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) BY EPIDERMAL-KERATINOCYTES DURING WOUND-HEALING [J].
BROWN, LF ;
YEO, KT ;
BERSE, B ;
YEO, TK ;
SENGER, DR ;
DVORAK, HF ;
VANDEWATER, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1375-1379
[10]
Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts [J].
Cairns, JA ;
Walls, AF .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (06) :1313-1321